Breast cancer and body weight index: the role of L-carnitine in prediction of answer to treatment and outcome of tumor in patients with obesity (review of literature).
DOI:
https://doi.org/10.26641/2307-0404.2018.1.124953Keywords:
body mass index (BMI), breast cancer (BC), obesity, overall survival, L-carnitineAbstract
Increasing the effectiveness of antitumor therapy in breast cancer patients who take L-carnitine during preoperative systemic antitumor therapy compared with patients receiving standard neoadjuvant systemic antitumor therapy served as a prerequisite for studying possible antitumor mechanisms of L-carnitine. The positive effect of L-carnitine is due to the transfer of palm-n-fatty acid through the inner membrane into the mitochondrial matrix, which contributes to the formation of a significant number of ATP molecules. It has also been shown that L-carnitine can have a double protective effect, enhancing the energy dynamics of the cell and inhibiting the hyperexcitability of the cell membrane, making it an ideal tool for the prevention and treatment of complications of antitumor therapy and concomitant metabolic disorders. This work summarizes the results of epidemiological and clinical studies on the use of L-carnitine in the treatment of breast cancer.
References
[Cancer in Ukraine. 2015-2016]. Byulleten Natsionalnogokantser-reestra Ukrainyi. Kyiv, 2017;18. Ukrainian.
Titov VN. [Functions of tochondria, carnitine, coenzyme-a, fatty acids, glucose, Randla i insulin cycle (lecture)]. Klinicheskaya laboratornaya diagnostika. 2012;2:32-42. Russian.
Porter NS, Jason LA, Boulton A, Bothne N, Coleman B. Alternative medical interventions used in the treatment and management of myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia. J Altern. Complement Med. 2010;16(3):235-49.
Bhandari R, Kelley GA, Hartley T. Metabolic syndrome is associated with increased breast cancer risk: a systematic review with meta-analysis. Int. J. Breast. Cancer. 2014;189384. doi: 10.1155/2014/189384
Chan DSM,VieiraAR, Aune D, Bandera EV, et.al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann. Oncol. 2014;25:1901-14. doi: 10.1093/annonc/mdu042
Bondarenko IN, Hojouj MIM. Body mass index as prognostic feature in breast cancer. 2nd International Cancer Study & Therapy Conference is going to be held during at Embassy Suites.InnerHarbor,Baltimore,USA; 2017.
Bondarenko IN, Hojouj MIM. Body mass index as a prognostic feature in breast cancer. 14th World Cancer & Anti-Cancer Therapy Convention. 2016. doi: 10.4172. – 1948–5956.C1.094.
CampbellCI, Petrik JJ. Moorehead RA. ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis. Mol. Cancer. 2010;9:35-250.
Rania M Khalil, Hoda A El-Bahrawy, Nahla E El- Ashmawy, Hossam Darwish. Carnitine Decreases Her-2 neu in Breast Cancer Patients Treated with Tamoxifen, IOSR. J Pharmacy Biological Sciences. 2013;5(I-2):91-98.
Doberenz j, Birkenfeld C, Kluge H, Eder K. Effects of L-carnitine supplementation in pregnant sows on plasma concentrations of insulin-like growth factors, various hormones and metabolites and chorion characteristics. J. Anim. Physiol. Anim. Nutr. 2006;90:11(12):487-99.
[Internet]. Available from: http://kharkov.dozor.ua/news/obwestvo/medicina/1183765.html
[Internet]. Available from: https://clinicaltrials.gov/ct2/results?cond=Breast+Cancer&term=L-carnitine&cntry=&state=&city=&dist=
[Internet]. Available from: https://clinicaltrials.gov/ct2/show/NCT00754767?term=L-carnitine&cond=Breast+Cancer&rank=1
[Internet]. Available from: http://www.who.int/mediacentre/factsheets/fs311/ru/
Husain S, Crosson C.T. Role of PKCepsilon in PGF2alpha-stimulated MMP-2 secretion from human ciliary muscle cells. J. Ocul. Pharmacol. Ther. 2008;24:268-77.
Fontanella C, Lederer D, Gade S, M. Vanoppen, et al. Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials. Breast. Cancer Res. Treat. 2015;150:127-39.
JordanVC, O’Malley BW. Selective estrogen-receptor modulators and antihormonal resistance in breast cancer. J Clin.Oncol. 2007;25:5815-24.
Kraemer WJ, Volek JS, Dunn-Lewis C. L-carnitine supplementation: influence upon physiological function. Curr. Sports Med. Rep. 2008;7(4):218-23.
Sener G, Ekşioğlu-Demiralp E, Cetiner M, Ercan F. et al. L-Carnitine ameliorates methotrexateinduced oxidative organ injury and inhibits leukocyte death. Cell. Biol. Toxicol. 2006;22:47-60.
Chan HL, Chou HC, Duran M, J. Gruenewald, et al. Major role of epidermal growth factor receptor and Srckinases in promoting oxidative stress-dependent loss of adhesion and apoptosis in epithelial cells. J. Biol. Chem. 2010;285(7):4307-18.
Pajares B, Pollán M, Martín M, Mackey JR, et al. Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis. Breast. Cancer Res. 2013;15:105.
Sparano JF, Wang M, Zhao F, Stearns V, et al. Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer. 2012;118:5937-46.
Neuhouser ML,AragakiAK, Prentice RL, Manson J.E, et al. Overweight, obesity, and postmenopausal invasive breast cancer risk: a secondary analysis of the women’s health initiative randomized clinical trials. JAMA Oncol. 2015;1:611-21.
Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast. Cancer Res.Treat. 2010;123:627-35.
Arcangeli A, Crociani O, Lastraioli E, A. Masi, et al. Targeting ionchannels in cancer: a novel frontier in antineoplastic therapy. Curr. Med. Chem. 2009;16(1):66-93.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2018 Medicni perspektivi
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
